Indapamide
      
      
      	
      		- 
      			Post Date:Feb 22,2019
- 
      			Expiry Date:Aug 21,2019
- 
      			Detailed Description:Cas No. :26807-65-8
			        
			        Specs:Purity: 99%-101%
 product Name indapamide
 Synonyms N-(4-CHLORO-3-SULFAMOYLBENZAMIDO)-2-METHYLINDOLINE ; N-[4-CHLORO-3-SULFAMOYL-BENZAMIDOL]-2-METHYLINDOLINE INDAPAMIDE ; 1-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline ; 3-(aminosulfonyl)-4-chloro-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)-benzamid ; 3-(aminosulfonyl)-4-chloro-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide ; 4-chloro-n-(2-methyl-1-indolinyl)-3-sulfamoyl-benzamid ; 4-chloro-n-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide ; bajaten ; damide ; fludex ; indaflex ; indamol ; ipamix ; lozol ; natrilix ; noranat ; s1520 ; se-1520 ; tandix ; INDAPAMID ; Indapamidum; ; 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide
 Molecular Formula C16H16ClN3O3S
 Molecular Weight 365.8345
 InChI InChI=1/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)
 CAS Registry Number 26807-65-8
 EINECS 248-012-7
 Molecular Structure
 Density 1.51g/cm3
 Refractive index 1.693
 Hazard Symbols
 Risk Codes
 Safety Description
 
- 
      			CAS Registry Number:26807-65-8
- 
      			Synonyms:;N-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline;N-[4-chloro-3-sulfamoyl-benzamidol]-2-methylindoline;1-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline;3-(aminosulfonyl)-4-chloro-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)-benzamid;3-(aminosulfonyl)-4-chloro-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide;4-chloro-n-(2-methyl-1-indolinyl)-3-sulfamoyl-benzamid;4-chloro-n-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide;bajaten;damide;fludex;indaflex;indamol;ipamix;lozol;natrilix;noranat;s1520;se-1520;tandix;INDAPAMID;Indapamidum;4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide;indaparnide;
- 
      			Molecular Formula:C16H16ClN3O3S
- 
      			Molecular Weight:365.8345
- 
      			Molecular Structure:  
 
      
      Inquiry